On Material Science Of Menghini Biopsy Needles And The Customization Philosophy Of Manners Technology

May 29, 2026

 

Liver biopsy covers a wide spectrum of tissue conditions, ranging from normal liver tissue to severe liver cirrhosis, as well as soft fatty liver lesions and hard tumors. No single universal needle can perfectly suit all clinical scenarios. The success of the Menghini liver biopsy needle stems not only from its ingenious negative pressure design, but also from its superior material properties that enable adaptability to diverse clinical applications. Leveraging strong customization capabilities, Manners Technology translates such inherent potential into practical solutions for complex clinical challenges.

Material Foundation: The Balance of Rigidity and Ductility of Medical-Grade Stainless Steel

Manners Technology adopts premium medical-grade stainless steel (304/316L series), a well-proven material with exceptional performance.

  • Biocompatibility and corrosion resistance: A stable passive film forms on the material surface, effectively resisting erosion from human tissue fluids and disinfectants to guarantee long-term safety.
  • Balanced strength and toughness: Liver biopsy requires sufficient rigidity for the needle to penetrate tough liver capsules and fibrotic tissues without bending during advancement. Meanwhile, proper ductility prevents brittle fracture when encountering unexpected resistance. Ideal mechanical properties are achieved via precise control over work hardening levels.
  • Machinability and batch consistency: Featuring excellent machinability, the stainless steel can be processed into intricate geometries via precision turning and laser cutting. This ensures uniform performance across all finished needles.

Customization: From Standard Products to Tailored Solutions

Standard Menghini needles are applicable to most adult patients. However, clinical practice presents highly variable conditions:

  • Varied patient physiques: Children and infants have smaller livers, calling for shorter and thinner needles to minimize procedural risks.
  • Special lesion locations: Lesions near the hepatic dome, diaphragm or major blood vessels require needles with specific lengths or tip angles for safe access under imaging guidance.
  • Differentiated pathological requirements: Certain research projects and specialized diagnoses, such as genetic testing, demand needles with larger inner lumens to retrieve thicker tissue strips.
  • Surgeon preferences: Practitioners may have individual requirements regarding handle tactility and syringe connection configurations.
  • Responsiveness to personalized demands stands as one of Manners Technology's core strengths. The company commits to delivering customized solutions based on customers' 2D/3D drawings or physical samples, which includes:
  • Flexible parameter adjustment: Key specifications can be modified on the basis of standard designs, such as overall needle length, effective working length, outer/inner diameter (Gauge) and bevel angle.
  • Complete material documentation: Material certification and BOM certificates are provided for all customized products, ensuring full quality transparency and traceability from raw materials to finished goods.
  • Collaborative design optimization: The in-house engineering team works alongside clinicians and medical device manufacturers to iterate designs according to clinical pain points and refine details for better compatibility with actual surgical workflows.

Conclusion

A high-performance Menghini biopsy needle unifies universal applicability and scenario-specific adaptability. With profound expertise in material science and mastery of precision manufacturing, Manners Technology delivers time-tested standard products while offering flexible customization tailored to special clinical needs.

Adhering to the development model of standardization as the foundation and customization as the extension, this classic Menghini design keeps pace with the advancement of modern precision medicine and continues to underpin accurate liver disease diagnosis.

news-1-1